Northern Trust’s OS Therapies Inc OSTX Stock Holding History

Northern Trust’s Portfolio OSTX Stock Details OSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Buy	70,817 +4,763	+7%	+$7.99K	﹤0.01%	4050
2026 Q1	$93.1K	Sell	66,054 -5,255	-7%	-$7.46K	﹤0.01%	4125
2025 Q4	$99.8K	Buy	71,309 +15,046	+27%	+$27.1K	﹤0.01%	4137
2025 Q3	$110K	Buy	+56,263	New	+$111K	﹤0.01%	4114

Other funds holding OSTX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Northern Trust's OSTX Position: Q2 2026 in Review

Northern Trust increased its OS Therapies Inc (OSTX) stake by 7.2% in Q2 2026, buying an estimated $7.99K and bringing the position to 70,817 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #4050.

Northern Trust first reported a position in OSTX in Q3 2025 and has held it in 4 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

Northern Trust held 70,817 shares of OS Therapies Inc worth $135K as of Q2 2026.
Northern Trust bought 4,763 OS Therapies Inc shares in Q2 2026, an estimated $7.99K.
OS Therapies Inc made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4050 holding.
Northern Trust first reported a position in OS Therapies Inc in Q3 2025 and has held it in 4 quarters since.
29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.